ARTA
ICPT

A.R.T. Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

A.R.T. Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,512
Closed -$1.05M – 1111
2019
Q4 		$1.05M Buy
+8,512
New +$762K 0.05% 530
2019
Q3 		– Sell
-7,864
Closed -$626K – 1802
2019
Q2 		$626K Sell
7,864
-753
-9% -$67.4K 0.04% 657
2019
Q1 		$964K Sell
8,617
-6,128
-42% -$670K 0.06% 497
2018
Q4 		$1.49M Buy
14,745
+8,600
+140% +$891K 0.1% 317
2018
Q3 		$776K Buy
+6,145
New +$650K 0.04% 682
2018
Q2 		– Sell
-26,245
Closed -$1.61M – 1837
2018
Q1 		$1.61M Sell
26,245
-38,800
-60% -$2.34M 0.06% 472
2017
Q4 		$3.8M Buy
+65,045
New +$4.1M 0.17% 152
2017
Q1 		– Sell
-6,500
Closed -$706K – 1783
2016
Q4 		$706K Buy
+6,500
New +$774K 0.04% 603
2016
Q1 		– Sell
-6,469
Closed -$966K – 1721
2015
Q4 		$966K Buy
+6,469
New +$1.1M 0.05% 580
2015
Q1 		– Sell
-23,317
Closed -$3.64M – 1755
2014
Q4 		$3.64M Buy
23,317
+1,681
+8% +$310K 0.14% 197
2014
Q3 		$5.12M Buy
21,636
+14,880
+220% +$3.79M 0.24% 100
2014
Q2 		$1.6M Buy
+6,756
New +$1.78M 0.08% 349

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

A.R.T. Advisors's ICPT Position: Q1 2020 in Review

A.R.T. Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2020, closing a stake of 8,512 shares — an estimated $1.05M sold.

A.R.T. Advisors first reported a position in ICPT in Q2 2014 and held it in 12 quarters. The position peaked at $5.12M in Q3 2014. 188 funds tracked by Wall St. Rank hold ICPT as of Q1 2020.

  • A.R.T. Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 8,512 Intercept Pharmaceuticals, Inc. shares in Q1 2020, an estimated $1.05M.
  • A.R.T. Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 12 quarters.
  • A.R.T. Advisors's Intercept Pharmaceuticals, Inc. position peaked at $5.12M in Q3 2014.
  • 188 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.